Download PDF
Semin Neurol 2010; 30(2): 186-191
DOI: 10.1055/s-0030-1249227
© Thieme Medical Publishers

Trigeminal Autonomic Cephalalgias: Paroxysmal Hemicrania, SUNCT/SUNA, and Hemicrania Continua

Peter J. Goadsby1 , 2 , Elisabetta Cittadini2 , Anna S. Cohen2
  • 1Headache Group, Department of Neurology, University of California San Francisco, San Francisco, California
  • 2Institute of Neurology, The National Hospital for Neurology and Neurosurgery, London, United Kingdom
Further Information

Publication History

Publication Date:
29 March 2010 (online)

    Permissions and Reprints

ABSTRACT

The trigeminal autonomic cephalalgias (TACs) are a group of primary headache disorders that include cluster headache (CH), paroxysmal hemicrania (PH), and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing/cranial autonomic features (SUNCT/SUNA). Hemicrania continua (HC) is often included with this group, although the second edition of The International Classification of Headache Disorders did not link the entities. Trigeminal autonomic cephalalgias are generally characterized by relatively short-lasting attacks of severe pain and lateralized associated features including the pain, cranial autonomic symptoms, and where present, migrainous symptoms, such as photophobia. Paroxysmal hemicrania has intermediate duration and intermediate attack frequency. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing has the shortest attack duration and the highest attack frequency. Hemicrania continua has a continuous pain with exacerbations that can include cranial autonomic symptoms as part of the phenotype. The syndromes share much in their pathophysiology and investigation paths; however, their treatment is distinct, so that the accurate differentiation is important for optimal management.

KEYWORDS

Paroxysmal hemicrania - SUNCT - SUNA - hemicrania continua

REFERENCES

  • 1 Goadsby P J, Lipton R B. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases.  Brain. 1997;  120(Pt 1) 193-209
    CrossrefPubMedGoogle Scholar
  • 2 Goadsby P J, Cohen A S, Matharu M S. Trigeminal autonomic cephalalgias: diagnosis and treatment.  Curr Neurol Neurosci Rep. 2007;  7(2) 117-125
    CrossrefPubMedGoogle Scholar
  • 3 Headache Classification Subcommittee of the International Headache Society . The international classification of headache disorders, 2nd edition.  Cephalalgia. 2004;  24(Suppl 1) 1-160
    PubMedGoogle Scholar
  • 4 Goadsby P J, Cittadini E, Burns B, Cohen A S. Trigeminal autonomic cephalalgias: diagnostic and therapeutic developments.  Curr Opin Neurol. 2008;  21(3) 323-330
    CrossrefPubMedGoogle Scholar
  • 5 Antonaci F, Sjaastad O. Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations.  Headache. 1989;  29(10) 648-656
    CrossrefPubMedGoogle Scholar
  • 6 Cittadini E, Matharu M S, Goadsby P J. Paroxysmal hemicrania: a prospective clinical study of 31 cases.  Brain. 2008;  131(Pt 4) 1142-1155
    CrossrefPubMedGoogle Scholar
  • 7 Boes C J, Dodick D W. Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients.  Headache. 2002;  42(8) 699-708
    CrossrefPubMedGoogle Scholar
  • 8 Irimia P, Cittadini E, Paemeleire K, Cohen A S, Goadsby P J. Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias.  Cephalalgia. 2008;  28(6) 626-630
    CrossrefPubMedGoogle Scholar
  • 9 Sjaastad O. Chronic paroxysmal hemicrania, hemicrania continua and SUNCT: the fate of the three first described cases.  J Headache Pain. 2006;  7(3) 151-156
    CrossrefPubMedGoogle Scholar
  • 10 Mathew N T, Kailasam J, Fischer A. Responsiveness to celecoxib in chronic paroxysmal hemicrania.  Neurology. 2000;  55(2) 316
    PubMedGoogle Scholar
  • 11 Lisotto C, Maggioni F, Mainardi F, Zanchin G. Rofecoxib for the treatment of chronic paroxysmal hemicrania.  Cephalalgia. 2003;  23(4) 318-320
    CrossrefPubMedGoogle Scholar
  • 12 Siow H C. Seasonal episodic paroxysmal hemicrania responding to cyclooxygenase-2 inhibitors.  Cephalalgia. 2004;  24(5) 414-415
    CrossrefPubMedGoogle Scholar
  • 13 Moore R A, Derry S, Makinson G T, McQuay H J. Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports.  Arthritis Res Ther. 2005;  7(3) R644-R665
    CrossrefPubMedGoogle Scholar
  • 14 Camarda C, Camarda R, Monastero R. Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate: two case reports.  Clin Neurol Neurosurg. 2008;  110(1) 88-91
    CrossrefPubMedGoogle Scholar
  • 15 Cohen A S, Goadsby P J. Paroxysmal hemicrania responding to topiramate.  J Neurol Neurosurg Psychiatry. 2007;  78(1) 96-97
    CrossrefPubMedGoogle Scholar
  • 16 Pascual J, Quijano J. A case of chronic paroxysmal hemicrania responding to subcutaneous sumatriptan.  J Neurol Neurosurg Psychiatry. 1998;  65(3) 407
    CrossrefPubMedGoogle Scholar
  • 17 Antonaci F, Pareja J A, Caminero A B, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua: lack of efficacy of sumatriptan.  Headache. 1998;  38(3) 197-200
    CrossrefPubMedGoogle Scholar
  • 18 Dahlöf C. Subcutaneous sumatriptan does not abort attacks of chronic paroxysmal hemicrania (CPH).  Headache. 1993;  33(4) 201-202
    CrossrefPubMedGoogle Scholar
  • 19 Afridi S K, Shields K G, Bhola R, Goadsby P J. Greater occipital nerve injection in primary headache syndromes—prolonged effects from a single injection.  Pain. 2006;  122(1-2) 126-129
    CrossrefPubMedGoogle Scholar
  • 20 Cohen A S, Matharu M S, Goadsby P J. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)—a prospective clinical study of SUNCT and SUNA.  Brain. 2006;  129(Pt 10) 2746-2760
    CrossrefPubMedGoogle Scholar
  • 21 Goadsby P J, Matharu M S, Boes C J. SUNCT syndrome or trigeminal neuralgia with lacrimation.  Cephalalgia. 2001;  21(2) 82-83
    CrossrefPubMedGoogle Scholar
  • 22 Pareja J A, Kruszewski P, Sjaastad O. SUNCT syndrome: trials of drugs and anesthetic blockades.  Headache. 1995;  35(3) 138-142
    CrossrefPubMedGoogle Scholar
  • 23 D'Andrea G, Granella F, Cadaldini M. Possible usefulness of lamotrigine in the treatment of SUNCT syndrome.  Neurology. 1999;  53(7) 1609
    CrossrefPubMedGoogle Scholar
  • 24 Leone M, Rigamonti A, Usai S, Damico D, Grazzi L, Bussone G. Two new SUNCT cases responsive to lamotrigine.  Cephalalgia. 2000;  20(9) 845-847
    CrossrefPubMedGoogle Scholar
  • 25 D'Andrea G, Granella F, Ghiotto N, Nappi G. Lamotrigine in the treatment of SUNCT syndrome.  Neurology. 2001;  57(9) 1723-1725
    CrossrefPubMedGoogle Scholar
  • 26 Gutierrez-Garcia J M. SUNCT syndrome responsive to lamotrigine.  Headache. 2002;  42(8) 823-825
    CrossrefPubMedGoogle Scholar
  • 27 Chakravarty A, Mukherjee A. SUNCT syndrome responsive to lamotrigine: documentation of the first Indian case.  Cephalalgia. 2003;  23(6) 474-475
    CrossrefPubMedGoogle Scholar
  • 28 Piovesan E J, Siow C, Kowacs P A, Werneck L C. Influence of lamotrigine over the SUNCT syndrome: one patient follow-up for two years.  Arq Neuropsiquiatr. 2003;  61(3A) 691-694
    PubMedGoogle Scholar
  • 29 Malik K, Rizvi S, Vaillancourt P D. The SUNCT syndrome: successfully treated with lamotrigine.  Pain Med. 2002;  3(2) 167-168
    CrossrefPubMedGoogle Scholar
  • 30 Cohen A S, Matharu M S, Goadsby P J. Suggested guidelines for treating SUNCT and SUNA.  Cephalalgia. 2005;  25 1200
    PubMedGoogle Scholar
  • 31 Matharu M S, Boes C J, Goadsby P J. SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate.  Neurology. 2002;  58(8) 1307
    CrossrefPubMedGoogle Scholar
  • 32 Rossi P, Cesarino F, Faroni J, Malpezzi M G, Sandrini G, Nappi G. SUNCT syndrome successfully treated with topiramate: case reports.  Cephalalgia. 2003;  23(10) 998-1000
    CrossrefPubMedGoogle Scholar
  • 33 Hunt C H, Dodick D W, Bosch E P. SUNCT responsive to gabapentin.  Headache. 2002;  42(6) 525-526
    CrossrefPubMedGoogle Scholar
  • 34 Porta-Etessam J, Benito-Leon J, Martinez-Salio A, Berbel A. Gabapentin in the treatment of SUNCT syndrome.  Headache. 2002;  42(6) 523-524
    CrossrefPubMedGoogle Scholar
  • 35 Graff-Radford S B. SUNCT syndrome responsive to gabapentin (Neurontin).  Cephalalgia. 2000;  20(5) 515-517
    CrossrefPubMedGoogle Scholar
  • 36 Cohen A S, Matharu M S, Goadsby P J. Double-blind placebo-controlled trial of topiramate in SUNCT.  Cephalalgia. 2007;  27 758
    PubMedGoogle Scholar
  • 37 Medina J L, Diamond S. Cluster headache variant. Spectrum of a new headache syndrome.  Arch Neurol. 1981;  38(11) 705-709
    PubMedGoogle Scholar
  • 38 Sjaastad O, Spierings E L. “Hemicrania continua”: another headache absolutely responsive to indomethacin.  Cephalalgia. 1984;  4(1) 65-70
    CrossrefPubMedGoogle Scholar
  • 39 Peres M FP, Silberstein S D, Nahmias S et al.. Hemicrania continua is not that rare.  Neurology. 2001;  57(6) 948-951
    CrossrefPubMedGoogle Scholar
  • 40 Wheeler S D, Allen K F, Pusey T. Is hemicrania continua a migraine variant?.  Cephalalgia. 2001;  21 508-509
    PubMedGoogle Scholar
  • 41 Pasquier F, Leys D, Petit H. “Hemicrania continua”: the first bilateral case?.  Cephalalgia. 1987;  7(3) 169-170
    CrossrefPubMedGoogle Scholar
  • 42 Iordanidis T, Sjaastad O. Hemicrania continua: a case report.  Cephalalgia. 1989;  9(4) 301-303
    CrossrefPubMedGoogle Scholar
  • 43 Trucco M, Antonaci F, Sandrini G. Hemicrania continua: a case responsive to piroxicam-beta-cyclodextrin.  Headache. 1992;  32(1) 39-40
    CrossrefPubMedGoogle Scholar
  • 44 Marano E, Giampiero V, Gennaro D R, di Stasio E, Bonusa S, Sorge F. “Hemicrania continua”: a possible case with alternating sides.  Cephalalgia. 1994;  14(4) 307-308
    CrossrefPubMedGoogle Scholar
  • 45 Newman L C, Spears R C, Lay C L. Hemicrania continua: a third case in which attacks alternate sides.  Headache. 2004;  44(8) 821-823
    CrossrefPubMedGoogle Scholar
  • 46 Matharu M S, Bradbury P, Swash M. Hemicrania continua: side alternation and response to topiramate.  Cephalalgia. 2006;  26(3) 341-344
    CrossrefPubMedGoogle Scholar
  • 47 Baldacci F, Nuti A, Cafforio G et al.. ‘INDOTEST’ in atypical hemicrania continua.  Cephalalgia. 2008;  28(3) 300-301
    CrossrefPubMedGoogle Scholar
  • 48 Newman L C, Lipton R B, Russell M, Solomon S. Hemicrania continua: attacks may alternate sides.  Headache. 1992;  32(5) 237-238
    CrossrefPubMedGoogle Scholar
  • 49 Bordini C, Antonaci F, Stovner L J, Schrader H, Sjaastad O. “Hemicrania continua”: a clinical review.  Headache. 1991;  31(1) 20-26
    CrossrefPubMedGoogle Scholar
  • 50 Newman L C, Lipton R B, Solomon S. Hemicrania continua: ten new cases and a review of the literature.  Neurology. 1994;  44(11) 2111-2114
    PubMedGoogle Scholar
  • 51 Peres M FP, Siow H C, Rozen T D. Hemicrania continua with aura.  Cephalalgia. 2002;  22(3) 246-248
    CrossrefPubMedGoogle Scholar
  • 52 Peres M FP, Zukerman E. Hemicrania continua responsive to rofecoxib.  Cephalalgia. 2000;  20(2) 130-131
    CrossrefPubMedGoogle Scholar
  • 53 Brighina F, Palermo A, Cosentino G, Fierro B. Prophylaxis of hemicrania continua: two new cases effectively treated with topiramate.  Headache. 2007;  47(3) 441-443
    CrossrefPubMedGoogle Scholar
  • 54 Burns B, Watkins L, Goadsby P J. Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study.  Lancet Neurol. 2008;  7 1001-1012
    CrossrefPubMedGoogle Scholar
  • 55 Goadsby P J. Lacrimation, conjunctival injection, nasal symptoms... cluster headache, migraine and cranial autonomic symptoms in primary headache disorders — what's new?.  J Neurol Neurosurg Psychiatry. 2009;  80(10) 1057-1058
    PubMedGoogle Scholar
  • 56 Lai T H, Fuh J L, Wang S J. Cranial autonomic symptoms in migraine: characteristics and comparison with cluster headache.  J Neurol Neurosurg Psychiatry. 2009;  80(10) 1116-1119
    CrossrefPubMedGoogle Scholar
  • 57 Levy M J, Matharu M S, Meeran K, Powell M, Goadsby P J. The clinical characteristics of headache in patients with pituitary tumours.  Brain. 2005;  128(Pt 8) 1921-1930
    CrossrefPubMedGoogle Scholar
  • 58 Cohen A S, Goadsby P J. Functional neuroimaging of primary headache disorders.  Expert Rev Neurother. 2006;  6(8) 1159-1171
    CrossrefPubMedGoogle Scholar
  • 59 Leone M, Patruno G, Vescovi A, Bussone G. Neuroendocrine dysfunction in cluster headache.  Cephalalgia. 1990;  10(5) 235-239
    CrossrefPubMedGoogle Scholar
  • 60 Favier I, van Vliet J A, Roon K I et al.. Trigeminal autonomic cephalgias due to structural lesions: a review of 31 cases.  Arch Neurol. 2007;  64(1) 25-31
    CrossrefPubMedGoogle Scholar
  • 61 Matharu M S, Levy M J, Merry R T, Goadsby P J. SUNCT syndrome secondary to prolactinoma.  J Neurol Neurosurg Psychiatry. 2003;  74(11) 1590-1592
    CrossrefPubMedGoogle Scholar
  • 62 Levy M J, Matharu M S, Goadsby P J. Prolactinomas, dopamine agonists and headache: two case reports.  Eur J Neurol. 2003;  10(2) 169-173
    CrossrefPubMedGoogle Scholar
  • 63 Bahra A, May A, Goadsby P J. Cluster headache: a prospective clinical study with diagnostic implications.  Neurology. 2002;  58(3) 354-361
    CrossrefPubMedGoogle Scholar

Professor Peter J GoadsbyM.D. 

Headache Group, Department of Neurology, UCSF Headache Center

1701 Divisadero Street, San Francisco, CA 94115

Email: peter.goadsby@ucsf.edu

      >